Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Strategy Asset Managers LLC

Strategy Asset Managers LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 26.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,023 shares of the medical equipment provider’s stock after selling 715 shares during the quarter. Strategy Asset Managers LLC’s holdings in Intuitive Surgical were worth $900,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Creekmur Asset Management LLC increased its position in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the last quarter. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at approximately $26,000. Able Wealth Management LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Delos Wealth Advisors LLC grew its position in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares during the period. Finally, MeadowBrook Investment Advisors LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 239 shares of the company’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $416.60, for a total value of $99,567.40. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,293,799.60. The sale was disclosed in a document filed with the SEC, which is available at this link. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 239 shares of the stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $416.60, for a total value of $99,567.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,293,799.60. The disclosure for this sale can be found here. Insiders have sold 51,656 shares of company stock worth $24,700,644 over the last three months. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 0.0 %

Shares of ISRG stock traded down $0.19 on Wednesday, reaching $483.25. 363,383 shares of the stock were exchanged, compared to its average volume of 1,513,428. The company has a market capitalization of $171.72 billion, a price-to-earnings ratio of 87.26, a PEG ratio of 5.43 and a beta of 1.39. The business’s 50 day moving average price is $456.78 and its 200 day moving average price is $416.47. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $493.97.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same period in the prior year, the firm posted $1.18 EPS. The business’s quarterly revenue was up 14.5% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ISRG. Stifel Nicolaus raised their price objective on Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. Barclays boosted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research note on Thursday, July 18th. Citigroup increased their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Truist Financial boosted their target price on Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research report on Tuesday, July 16th. Finally, Evercore ISI lowered their price target on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research report on Friday, July 19th. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $446.45.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.